Bortezomib resistance mutations in PSMB5 determine response to second-generation proteasome inhibitors in multiple myeloma.
Kira AllmerothMoritz HornVirginia KroefStephan MietheRoman-Ulrich MüllerMartin Sebastian DenzelPublished in: Leukemia (2020)
Keyphrases